10 Biotech Trades for Second Half of 2011

Description:

According to Adam Feuerstein, "The biotech calendar for the second half of 2011 is filled with drug approval decisions and clinical trial outcomes, enough to keep biotech stocks jumping for the remainder of the year." Read more here.

>>Also: 10 Cheap Biotech Stocks That Could Soar

>>Also: 5 Dow Stocks Likely to Rise After Earnings

Portfolio not tracked.

Most Viewed Portfolios

View All

Articles

5 Stocks Set to Soar on Bullish Earnings

09.30.14 | 02:34 PM

DELAFIELD, Wis. (Stockpickr) -- Short-sellers hate being caught short a stock that reports a blowout quarter. When this happens, we often see a tra...

Buy These 5 Momentum Movers to Stomp the S&P

09.30.14 | 12:12 PM

BALTIMORE (Stockpickr) -- Now that five of the last seven sessions have ended lower in the S&P 500, Mr. Market is giving is a reminder that stock ...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter